---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-102375"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T21:14:00.679148+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q2 EPS $0.46, Adjusted $0.53; raises FY 2025 EBITDA guidance to $245-255M

## Summary
- Net revenue $469M; net income $39M vs. loss of $153M a year ago due to non-cash impairment.
- Adjusted EBITDA $73M, up from $58M in Q2 2024; raised FY guidance to $245-255M (from $220-240M).
- Same-unit revenue +6.4% with neonatology NICU days up 6.0% year-over-year.
- Cash from continuing operations $138M; total debt $606M; no revolver borrowings.

## SEC filing metadata
- accession: 0000950170-25-102375
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017025102375/0000950170-25-102375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017025102375/md-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-102375
- JSON: https://secwatch.observer/filing/0000950170-25-102375.json
- Plain text: https://secwatch.observer/filing/0000950170-25-102375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.